Thyrotoxic Periodic Paralysis: An Update

Jayanta Chakraborty, Semanti Chakraborty, Rita Moitra

Abstract


Thyrotoxic periodic paralysis (TPP) is an endocrine emergency. In initial hours, it requires multidisciplinary care as it involves heart and nervous system. Early diagnosis demands highest clinical acumen as symptoms and signs of thyrotoxicosis are often subtle. TPP is not nowadays confined to particular ethnic groups. Different cellular ion channels have been identified in its etiopathogenesis. Definitive treatment of thyrotoxicosis is also important to prevent relapse. In all cases of hypokalemia in emergency room, TPP should be excluded. of hypokalemia should be rationalized to prevent rebound hyperkalemia as total body potassium loss is minimum or nil. Patients should be made euthyroid as soon as possible to prevent relapse of TPP. Future research on ethnic variation of Na+-K+ ATPase activity may enlighten us the cause of higher prevalence in Asians.




J Endocrinol Metab. 2020;10(3-4):60-62
doi: https://doi.org/10.14740/jem662

Keywords


Hypokalemic periodic paralysis; Thyrotoxic periodic paralysis; Graves disease; Na+ - K+ ATPase; Kir2.6 channel (KCNJ18)

Full Text: HTML PDF
 

Browse  Journals  

 

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

 

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

 

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

 

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

 

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 
       
 

Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jofem.org   editorial contact: editor@jofem.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.